References
- Anderson W. F. Human gene therapy. Science (1992); 256: 808–813
- Miller A. D. Progress toward human gene therapy. Blood (1990); 76: 271–278
- Verma I. M. Gene therapy. Scientific American (1990); 68–84
- Friedmann T. Progress toward human gene therapy. Science (1989); 244: 1275–1281
- Huber B. E., Richards C. A., Krenitsky T. A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA (1991); 88: 8039–8043
- Richards C. A., Wolberg A. S., Huber B. E. The transcriptional control region of the human carcinoembryonic antigen gene: DNA sequence and homology studies. DNA Sequence (1993); 4: 185–196
- Austin E. A., Huber B. E. A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharm. (1993); 43: 380–387
- Huber B. E., Austin E. A., Good S. S., Knick V. C., Tibbels S., Richards C. A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. (1993); 53: 4619–4626
- Richards C. A., Huber B. E. Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. Human Gene Therapy (1993); 4: 143–150
- Huber B. E., Austin E. A., Richards C. A., Davis S T, Good S. S. Metabolism of 5-flurocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA (1994); 92: 8302–8306
- Richards C. A., Austin E. A., Huber B. E. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy. Human Gene Therapy
- Knowles B. B., Howe C. C., Aden D. P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science (1980); 209: 497–499
- Huber B. E., Dearfield K. L., Williams J. R., Heilman C. A., Thorgeirsson S. S. Tumorigenicity and transcriptional modulation of C-Myc and N-ras oncogenes in a human hepatoma cell line. Cancer Res. (1985); 45: 4322–4329
- Averett D. A., Koszalka G. W., Fyfe J. A., Roberts G. B., Purifoy D. J.M., Krenitsky T. A. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus. Antimicrob. Agents Chemother. (1991); 35: 851–857
- Kotani H., Newton P. B., Zhang S., Chiang Y. L., Otto E., Weaver L., Blaese R. M., Anderson W. F., McGarrity G. J. Improved methods of retroviral vector transduction and production for gene therapy. Human Gene Therapy (1994); 5: 19–28
- Donahue R. E., Kessler S. W., Bondine D., McDonagh K., Dunbar C., Goodman S., Agricola B., Byrne E., Raffeld M., Moen R., Bacher J., Zsebo K. M, Nienhuis A. W. Helper virus induced T-cell lymphoma in non-human primates after retroviral mediated gene transfer. J. Exp. Med. (1992); 376: 1125–1135
- Kay M. A., Li Q., Liu T. J., Leland F., Toman C., Finegold M., Woo S. L. Hepatic gene therapy: persistent expression of human a-1-antitrypsin in mice after direct gene delivery in vivo. Human Gene Therapy (1992); 3: 641–647
- Peng H., Armentano D., MacKenzie-Graham L., Shen R. F., Darlington Ledley F. D., Woo S. L.C. Retroviral-mediated gene transfer and expression of human phenylalanine hydroxylase in primary mouse hepatocytes. Proc. Natl. Acad. Sci. USA (1988); 85: 8146–8150
- Cone R. D., Weber-Benarous A., Baorto D., Mulligan R. C. Regulated expression of a complete human B-globin gene encoded by a transmissible retrovirus vector. Mol. Cell Biol. (1987); 7: 887–897
- Andersen Garber J. K.D.A., Meaney C. A., Breakfield X. O. Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial Lac Z in neurons using the neuron-specific enolase promoter. Human Gene Therapy (1992); 3: 487–499
- Vile R. G., Hart I. R. vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res. (1993); 53: 962–967
- Smith M. J., Rousculp M. D., Goldsmith K. T., Curiel D. T., Garver R. I. Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. Hum. Gene Therapy (1994); 5: 29–35
- Osaki T., Tanio Y., Tachibana I., Hosoe S., Kumagai T., Kawase I., Oikawa S., Kishimoto T. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of Herpes Simplex Virus thymidine kinase gene. Cancer Res. (1994); 54: 5258–5261
- Manome Y., Abe M., Hagen M. F., Fine H. A., Kufe D. W. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymide kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res. (1994); 54: 5408–5413
- Nakata K., Motomura M., Nakabayashi H., Ido A., Tamaoki T. A possible mecanism of inverse developmental regulation of a-fetoprotein and albumin genes: studies with epidermal growth factor and phorbol ester. J. Biol. Chem (1992); 267: 1331–1334